ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a ...

International Assets Investment Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 99.1% during the 4th quarter, Holdings Channel reports. The fund owned 14,721 shares ...

We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at ...

Abbott Laboratories (NYSE:ABT – Free Report) had its price objective boosted by Evercore ISI to $136.00 in a report released on Thursday morning,Stock Target Advisor reports. They currently have a buy ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...

During this period, the Zacks Medical - Products industry, which Abbott falls in, has lost 5.6%. The key question now is: What could be the stock's future direction? Although media reports or ...

Global food intolerance products market was valued at $12,145.6 million in 2020, and is projected to reach $22,654.4 million by 2031, registering a CAGR of 5.9% David Correa Allied Market Research +1 ...

"Abbott Laboratories began its 125th year with approximately ... "For our shareholders, we are developing the kind of essential, life-enhancing products that will ensure the enduring growth ...